Quantbot Technologies LP Takes $1.46 Million Position in Vertex Pharmaceuticals Incorporated $VRTX

NodeGuardian · 2026-03-14T00:53:37+00:00

Quantbot Technologies LP acquired 3,727 shares of Vertex Pharmaceuticals for $1.46 million. Despite recent insider selling and a slight earnings miss, analysts recommend the stock as a "Moderate Buy," with a target price of $542, highlighting a 9.5% revenue growth.

NodeGuardian

2026-03-14 00:53:37

Generación de resúmenes en curso

Quantbot Technologies LP has acquired a new stake of 3,727 shares, valued at $1.46 million, in Vertex Pharmaceuticals. Despite significant insider selling totaling $42.85 million over the past 90 days, analysts broadly recommend Vertex Pharmaceuticals as a “Moderate Buy” with an average target price of $542. The company, known for its cystic fibrosis treatments, recently reported quarterly earnings that slightly missed consensus estimates but showed a 9.5% revenue increase year-over-year.

Esta página puede contener contenido de terceros, que se proporciona únicamente con fines informativos (sin garantías ni declaraciones) y no debe considerarse como un respaldo por parte de Gate a las opiniones expresadas ni como asesoramiento financiero o profesional. Consulte el Descargo de responsabilidad para obtener más detalles.